Compare AbbVie Inc (ABBV) vs Waste Management, Inc. (WM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbbVie Inc vs Waste Management, Inc. — how do they compare? AbbVie Inc trades at $249.5 (market cap $438.19B), while Waste Management, Inc. trades at $226.1 (market cap $90.58B). The key difference: AbbVie Inc is far larger — about 4.8× Waste Management, Inc.'s market cap, and AbbVie Inc pays the higher dividend (2.79%). Which is the better fit depends on your goals.
| ABBV | WM | |
|---|---|---|
Market Cap | $438.19B | $90.58B |
Sector | Health | Industrials |
52-Week High | $263.58 | $246.51 |
52-Week Low | $197.38 | $196.77 |
Enterprise Value | $502.45B | $113.37B |
Dividend Yield | 2.79% | 1.56% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABBV trades at $247.91, up 0.76% today, with a bullish technical signal supported by moving averages and oversold RSI levels. The company reported Q2 2026 EPS of $3.65, beating expectations, and maintains strong profitability with a 71.48% gross margin. Recent news highlights positive Phase 2 data for ELAHERE in ovarian cancer, reinforcing growth prospects beyond Humira's patent expiry.
Outlook is positive with analyst consensus target of $278.69, though high P/E of 70.05 and debt levels pose valuation and financial risks. Revenue growth driven by Skyrizi and Rinvoq offsets competitive pressures, but patent cliffs in the 2030s require monitoring. The stock offers dividend appeal with a $1.73 payout scheduled for August 2026.
WM trades at $227.68, down 0.58% on the day, with a bullish technical signal supported by moving averages and oversold RSI levels. The company reported Q2 2026 EPS of $2.02, beating estimates, with revenue growth to $25.2 billion in 2025. Valuation ratios are elevated, with a P/E of 59.96 and P/S of 16.1, reflecting premium pricing. Recent news highlights margin gains and institutional activity, including Bank of America reducing holdings by 6.1% in Q1 2026 (Defense World, 2026-08-01).
The outlook remains positive with a consensus price target of $263.43, implying 15.7% upside, driven by pricing discipline and technology investments. Risks include high debt levels, with a debt-to-asset ratio of 53.62% in 2024, and softer volume trends. Earnings momentum from recent beats supports growth, but margin pressures and economic sensitivity could limit gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About Waste Management, Inc.
Waste Management ranks as the largest integrated provider of traditional solid waste services in the United States, operating approximately 260 active landfills and about 340 transfer stations. The company serves residential, commercial, and industrial end markets and is also a leading recycler in North America.
Read more on WM →
